[1]白春昀,翁稚颖,肖创,等.慢性阻塞性肺病相关炎症细胞及因子的研究进展[J].慢性病学杂志,2019,20(01):42-46.
点击复制
慢性阻塞性肺病相关炎症细胞及因子的研究进展(PDF)
《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]
- 卷:
- 20
- 期数:
- 2019年01期
- 页码:
- 42-46
- 栏目:
- 综 述
- 出版日期:
- 2019-01-30
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- R563.9
- DOI:
- -
- 摘要:
- 慢性阻塞性肺病（COPD） 是以暴露于有毒气体或颗粒物中而导致气道和肺泡异常所引起的持续呼吸道症 状及以气流受限为特征的肺部疾病。COPD 由遗传与环境因素共同作用，炎性反应是COPD 的主要致病机制，与 COPD 相关的炎症细胞主要有：中性粒细胞、T 淋巴细胞、肺泡巨噬细胞、嗜酸性粒细胞，相关炎症因子有：白 介素-6 （IL-6）、白介素-17 （IL-17）、白三烯B4 （LTB4）
- Abstract:
- -
参考文献/References:
[1] 2018 Global Initiative for Chronic Obstructive Lung Disease,
2018.
[2] Adeloye D, Chua S, Lee C, et al. Global and regional estimates
of COPD prevalence: Systematic review and metaanalysis
[J]. J Glob Health, 2015,5(2):20415.
[3] Agusti A, Celli B, Faner R. What does endotyping mean
for treatment in chronic obstructive pulmonary disease? [J].
Lancet, 2017,390(10098):980-987.
[4] Sandhaus RA, Stoller JK. Introduction to the 50th anniversary
of the description of alpha- 1 antitrypsin deficiency [J].
COPD, 2013,10(1):1-2.
[5] Parr DG, Lara B. Clinical utility of alpha- 1 proteinase inhibitor
in the management of adult patients with severe alpha-
1 antitrypsin deficiency: a review of the current literature
[J]. Drug Des Devel Ther, 2017(11):2149-2162.
[6] Yao H, Rahman I. Current concepts on oxidative/carbonyl
stress, inflammation and epigenetics in pathogenesis of
chronic obstructive pulmonary disease [J]. Toxicol Appl
Pharmacol, 2011,254(2):72-85.
[7] Chung KF, Adcock IM. Multifaceted mechanisms in
COPD: inflammation, immunity, and tissue repair and destruction
[J]. Eur Respir J, 2008,31(6):1334-1356.
[8] Andersen ZJ, Hvidberg M, Jensen SS, et al. Chronic obstructive
pulmonary disease and long- term exposure totraffic- related air pollution: a cohort study [J]. Am J
Respir Crit Care Med, 2011,183(4):455-461.
[9] Sethi S, Murphy TF. Infection in the pathogenesis and
course of chronic obstructive pulmonary disease [J]. N
Engl J Med, 2008,359(22):2355-2365.
[10] Ko FW, Chan KP, Hui DS, et al. Acute exacerbation of
COPD [J]. Respirol, 2016,21(7):1152-1165.
[11] Mebratu YA, Smith KR, Agga GE, et al. Inflammation
and emphysema in cigarette smoke-exposed mice when instilled
with poly (I:C) or infected with influenza A or respiratory
syncytial viruses [J]. Respir Res, 2016,17(1):75.
[12] Presti RM, Flores SC, Palmer BE, et al. Mechanisms
Underlying HIV- Associated Noninfectious Lung Disease
[J]. Chest, 2017,152(5):1053-1060
[13] Kou YR, Kwong K, Lee LY. Airway inflammation and
hypersensitivity induced by chronic smoking [J]. Respir
Physiol Neurobiol, 2011,178(3):395-405.
[14] Sampson AP. The role of eosinophils and neutrophils in inflammation
[J]. Clin Exp Allergy, 2000,30(Suppl 1):22-27.
[15] Messer JW, Peters GA, Bennett WA. Causes of death
and pathologic findings in 304 cases of bronchial asthma
[J]. Dis Chest, 1960,38(6):616-624.
[16] Bafadhel M, Pavord ID, Russell R. Eosinophils in COPD:
just another biomarker [J]. Lancet Respir Med, 2017,5(9):
747-759.
[17] Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations
of chronic obstructive pulmonary disease: identification
of biologic clusters and their biomarkers [J]. Am J
Respir Crit Care Med, 2011,184(6):662-671.
[18] Saha S, Brightling CE. Eosinophilic airway inflammation
in COPD [J]. Int J Chron Obstruct Pulmon Dis, 2006,1(1):
39-47.
[19] Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils
to direct corticosteroid treatment of exacerbations of
chronic obstructive pulmonary disease: a randomized placebo-
controlled trial [J]. Am J Respir Crit Care Med, 2012,
186(1):48-55.
[20] Hartjes FJ, Vonk JM, Faiz A, et al. Predictive value of
eosinophils and neutrophils on clinical effects of ICS in
COPD [J]. Respirol, 2018.
[21] 郑春明,李论,黄克武.外周血嗜酸性粒细胞与慢性阻塞性肺疾病
急性加重期住院患者临床转归的相关性分析[J].中国临床医生杂
志,2016,44(10):42-44.
[22] Kim SR, Rhee YK. Overlap Between Asthma and COPD:
Where the Two Diseases Converge [J]. Allergy Asthma
Immunol Res, 2010,2(4):209-214.
[23] van Gemert F, Kirenga B, Chavannes N, et al. Prevalence
of chronic obstructive pulmonary disease and associated
risk factors in Uganda (FRESH AIR Uganda): a prospective
cross- sectional observational study [J]. Lancet
Glob Health, 2015,3(1):e44-e51.
[24] Wright TK, Gibson PG, Simpson JL, et al. Neutrophil
extracellular traps are associated with inflammation in
chronic airway disease [J]. Respirol, 2016,21(3):467-475.
[25] Overbeek SA, Braber S, Koelink PJ, et al. Cigarette
smoke-induced collagen destruction; key to chronic neutrophilic
airway inflammation? [J]. PLoS One, 2013,8(1):
e55612.
[26] Hill AT, Bayley D, Stockley RA. The interrelationship of
sputum inflammatory markers in patients with chronic bronchitis
[J]. Am J Respir Crit Care Med, 1999,160(3):893-
898.
[27] Tuder RM, Petrache I. Pathogenesis of chronic obstructive
pulmonary disease [J]. J Clin Invest, 2012,122(8):2749-
2755.
[28] 吴艳军,于刚刚,李云霄,等. 中性粒细胞在慢性阻塞性肺疾病中
的临床意义探讨[J].中国医刊,2018,53(5):497-500.
[29] Papi A, Bellettato CM, Braccioni F, et al. Infections and
airway inflammation in chronic obstructive pulmonary disease
severe exacerbations [J]. Am J Respir Crit Care
Med, 2006,173(10):1114-1121.
[30] Dockrell DH, Marriott HM, Prince LR, et al. Alveolar
macrophage apoptosis contributes to pneumococcal clearance
in a resolving model of pulmonary infection [J]. J Immunol,
2003,171(10):5380-5388.
[31] Dong R, Xie L, Zhao K, et al. Cigarette smoke- induced
lung inflammation in COPD mediated via LTB4/BLT1/
SOCS1 pathway [J]. Int J Chron Obstruct Pulmon Dis,
2016(11):31-41.
[32] Barnes PJ. Cellular and molecular mechanisms of chronic
obstructive pulmonary disease [J]. Clin Chest Med, 2014,
35(1):71-86.
[33] Bewley MA, Preston JA, Mohasin M, et al. Impaired Mitochondrial
Microbicidal Responses in Chronic Obstructive
Pulmonary Disease Macrophages [J]. Am J Respir Crit
Care Med, 2017,196(7):845-855.
[34] Berenson CS, Kruzel RL, Eberhardt E, et al. Impaired innate
immune alveolar macrophage response and the predilection
for COPD exacerbations [J]. Thorax, 2014,69(9):
811-818.
[35] Liu G, Yang H. Modulation of macrophage activation and
programming in immunity [J]. J Cell Physiol, 2013,228(3):
502-512.
[36] Cheng C, Huang C, Ma TT, et al. SOCS1 hypermethylation
mediated by DNMT1 is associated with lipopolysaccharide-
induced inflammatory cytokines in macrophages
[J]. Toxicol Lett, 2014,225(3):488-497.
[37] Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive
pulmonary disease: molecular and cellular mechanisms [J].
Eur Respir J, 2003,22(4):672-688.
[38] Majo J, Ghezzo H, Cosio MG. Lymphocyte population
and apoptosis in the lungs of smokers and their relation toemphysema [J]. Eur Respir J, 2001,17(5):946-953.
[39] den Otter I, Willems LN, van Schadewijk A, et al. Lung
function decline in asthma patients with elevated bronchial
CD8, CD4 and CD3 cells [J]. Eur Respir J, 2016,48(2):
393-402.
[40] Boulet LP, Turcotte H, Turcot O, et al. Airway inflammation
in asthma with incomplete reversibility of airflow
obstruction [J]. Respir Med, 2003,97(6):739-744.
[41] Maeno T, Houghton AM, Quintero PA, et al. CD8
+ T
Cells are required for inflammation and destruction in cigarette
smoke- induced emphysema in mice [J]. J Immunol,
2007,178(12):8090-8096.
[42] Lewis JB, Hirschi KM, Arroyo JA, et al. Plausible Roles
for RAGE in Conditions Exacerbated by Direct and Indirect
(Secondhand) Smoke Exposure [J]. Int J Mol Sci,
2017,18(3):652.
[43] Bettelli E, Korn T, Kuchroo VK. Th17: the third member
of the effector T cell trilogy [J]. Curr Opin Immunol,
2007,19(6):652-657.
[44] Duan MC, Tang HJ, Zhong XN, et al. Persistence of
Th17/Tc17 cell expression upon smoking cessation in
mice with cigarette smoke- induced emphysema [J]. Clin
Dev Immunol, 2014,2013(9):350727.
[45] Duan MC, Zhang JQ, Liang Y, et al. Infiltration of IL-
17- Producing T Cells and Treg Cells in a Mouse Model
of Smoke- Induced Emphysema [J]. Inflammation, 2016,39
(4):1334-1344.
[46] Podolin PL, Foley JP, Carpenter DC, et al. T cell depletion
protects against alveolar destruction due to chronic cigarette
smoke exposure in mice [J]. Am J Physiol Lung
Cell Mol Physiol, 2013,304(5):L312-L323.
[47] Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers
improve clinical prediction of mortality in chronic
obstructive pulmonary disease [J]. Am J Respir Crit Care
Med, 2012,185(10):1065-1072.
[48] Ravi AK, Khurana S, Lemon J, et al. Increased levels of
soluble interleukin- 6 receptor and CCL3 in COPD sputum
[J]. Respir Res, 2014,15(1):103.
[49] 张旭东.呼出气冷凝液检测炎性指标监测在慢性阻塞性肺疾病患
者中的临床应用[J].中国老年学杂志,2014,34(11):2988-2990.
[50] Farahi N, Paige E, Balla J, et al. Neutrophil- mediated
IL- 6 receptor trans- signaling and the risk of chronic obstructive
pulmonary disease and asthma [J]. Hum Mol
Genet, 2017,26(8):1584-1596.
[51] Park SJ, Lee YC. Interleukin- 17 regulation: an attractive
therapeutic approach for asthma [J]. Respir Res, 2010,11
(1):78
[52] Le Rouzic O, Pichavant M, Frealle E, et al. Th17 cytokines:
novel potential therapeutic targets for COPD pathogenesis
and exacerbations [J]. Eur Respir J, 2017,50(4):
1602434.
[53] 周正,王艳丽. 慢性阻塞性肺疾病患者血浆IL-17 水平变化及其
与IL- 6、LTB4 的相关性[J]. 江苏医药,2010,36(17):1997-
1999.
[54] Chang Y, Nadigel J, Boulais N, et al. CD8 positive T
cells express IL- 17 in patients with chronic obstructive
pulmonary disease [J]. Respir Res, 2011,12(1):43.
[55] Mebratu YA, Tesfaigzi Y. IL-17 Plays a Role in Respiratory
Syncytial Virus- induced Lung Inflammation and Emphysema
in Elastase and LPS- injured Mice [J]. Am J
Respir Cell Mol Biol, 2018,58(6):717-726.
[56] Dong R, Xie L, Zhao K, et al. Cigarette smoke- induced
lung inflammation in COPD mediated via LTB4/BLT1/
SOCS1 pathway [J]. Int J Chron Obstruct Pulmon Dis,
2016,11(default):31-41.
[57] De Hoog VC, Bovens SM, de Jager SC, et al. BLT1 antagonist
LSN2792613 reduces infarct size in a mouse model
of myocardial ischaemia- reperfusion injury [J]. Cardiovasc
Res, 2015,108(3):367-376.
[58] Beeh KM, Kornmann O, Buhl R, et al. Neutrophil chemotactic
activity of sputum from patients with COPD: role of
interleukin 8 and leukotriene B4 [J]. Chest, 2003,123(4):
1240-1247.
[59] Dong XQ, Shen Q, Yao YN, et al. Determination of biomarkers
in exhaled breath condensation of acute exacerbation
of chronic obstructive pulmonary disease and its clinical
implications [J]. Zhonghua Jie He He Hu Xi Za Zhi,
2017,40(2):114-117.
备注/Memo
- 备注/Memo:
- 基金项目：国家自然科学基金（81870037，81860012， 81402991）；云南省科技厅重点项目 （2017FA043，2014BC012，2014IA033） 作者简介：白春昀，硕士，研究方向：呼吸药理学 通信作者：杨为民，E-mail：15887299927@yeah.net
常用功能
统计/Statistics
- 摘要浏览/Viewed914
- 全文下载/Downloads699
- 评论/Comments
